Michael R. Jordan

9.6k total citations · 2 hit papers
122 papers, 4.6k citations indexed

About

Michael R. Jordan is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Michael R. Jordan has authored 122 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Infectious Diseases, 68 papers in Virology and 19 papers in Epidemiology. Recurrent topics in Michael R. Jordan's work include HIV/AIDS Research and Interventions (80 papers), HIV/AIDS drug development and treatment (73 papers) and HIV Research and Treatment (68 papers). Michael R. Jordan is often cited by papers focused on HIV/AIDS Research and Interventions (80 papers), HIV/AIDS drug development and treatment (73 papers) and HIV Research and Treatment (68 papers). Michael R. Jordan collaborates with scholars based in United States, Switzerland and United Kingdom. Michael R. Jordan's co-authors include Silvia Bertagnolio, Robert W. Shafer, Diane Bennett, James McMahon, Alan L. Balch, Roy H. Bible, Steven Stevenson, J. Craft, Kim Harich and Kalyani Maitra and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Michael R. Jordan

118 papers receiving 4.5k citations

Hit Papers

Small-bandgap endohedral metallofullerenes in high yield ... 1999 2026 2008 2017 1999 2009 250 500 750

Peers

Michael R. Jordan
Indira Hewlett United States
William A. Schleif United States
Christopher L. King United States
Eugene Sun United States
Margaret Tisdale United Kingdom
Michelle Gordon South Africa
Michael R. Jordan
Citations per year, relative to Michael R. Jordan Michael R. Jordan (= 1×) peers Antonella Cingolani

Countries citing papers authored by Michael R. Jordan

Since Specialization
Citations

This map shows the geographic impact of Michael R. Jordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Jordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Jordan more than expected).

Fields of papers citing papers by Michael R. Jordan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Jordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Jordan. The network helps show where Michael R. Jordan may publish in the future.

Co-authorship network of co-authors of Michael R. Jordan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Jordan. A scholar is included among the top collaborators of Michael R. Jordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Jordan. Michael R. Jordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nutt, Cameron T., Richard Lessells, Winnie Muyindike, et al.. (2025). Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries With the Highest Adult HIV Prevalence. Clinical Infectious Diseases. 82(2). 265–273.
3.
Morbioli, Giorgio Gianini, Jessica C. Brooks, Ewaldé Cutler, et al.. (2025). Clinical evaluation of patterned dried plasma spot cards to support quantification of HIV viral load and reflexive genotyping. Proceedings of the National Academy of Sciences. 122(7). e2419160122–e2419160122. 2 indexed citations
5.
Chu, Carolyn, Kaiming Tao, Ava Avalos, et al.. (2024). Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review. Viruses. 16(3). 399–399. 23 indexed citations
6.
Taylor, Elizabeth Johnston, et al.. (2023). Tragedy or transformation? Online survey of nurse spirituality during the COVID pandemic. Journal of Clinical Nursing. 32(17-18). 6287–6297. 5 indexed citations
7.
Jordan, Michael R., Nicholus Mutenda, Gillian Hunt, et al.. (2022). Pretreatment Human Immunodeficiency Virus (HIV) Drug Resistance Among Treatment-Naive Infants Newly Diagnosed With HIV in 2016 in Namibia: Results of a Nationally Representative Study. Open Forum Infectious Diseases. 9(5). ofac102–ofac102. 3 indexed citations
8.
Inzaule, Seth, Michael R. Jordan, George Bello, et al.. (2020). High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan Africa. AIDS. 34(10). 1567–1570. 7 indexed citations
9.
Ghafari, Shokouh, Arash Memarnejadian, Alireza Samarbafzadeh, et al.. (2017). Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naïve persons in the Southwest of Iran, 2014-2015. Archives of Virology. 162(9). 2737–2745. 9 indexed citations
10.
Clutter, Dana, Michael R. Jordan, Silvia Bertagnolio, & Robert W. Shafer. (2016). HIV-1 drug resistance and resistance testing. Infection Genetics and Evolution. 46. 292–307. 216 indexed citations
11.
Trotter, Andrew, et al.. (2014). Systematic review of HIV drug resistance in Southeast Asia.. PubMed. 15(3). 162–70. 14 indexed citations
12.
McMahon, James, Anand Manoharan, Christine Wanke, et al.. (2013). Pharmacy and Self-Report Adherence Measures to Predict Virological Outcomes for Patients on Free Antiretroviral Therapy in Tamil Nadu, India. AIDS and Behavior. 17(6). 2253–2259. 17 indexed citations
13.
Hong, Steven Y., Steven A. Cohen, Jean B. Nachega, et al.. (2013). Medication Possession Ratio Associated with Short-Term Virologic Response in Individuals Initiating Antiretroviral Therapy in Namibia. PLoS ONE. 8(2). e56307–e56307. 34 indexed citations
14.
Shao, Wei, Irene Bontell, Fatim Cham, et al.. (2013). Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys. Infection Genetics and Evolution. 18. 125–131. 37 indexed citations
15.
Parkin, Neil, Carmen de Mendoza, Rob Schuurman, et al.. (2012). Evaluation of In-house Genotyping Assay Performance Using Dried Blood Spot Specimens in the Global World Health Organization Laboratory Network. Clinical Infectious Diseases. 54(suppl 4). S273–S279. 21 indexed citations
17.
Hunt, Gillian, Johanna Ledwaba, Adriaan E. Basson, et al.. (2012). Surveillance of Transmitted HIV-1 Drug Resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005–2009. Clinical Infectious Diseases. 54(suppl_4). S334–S338. 34 indexed citations
18.
Bertagnolio, Silvia, Martina Penazzato, Michael R. Jordan, et al.. (2012). World Health Organization Generic Protocol to Assess Drug-Resistant HIV Among Children <18 Months of Age and Newly Diagnosed With HIV in Resource-Limited Countries. Clinical Infectious Diseases. 54(suppl_4). S254–S260. 17 indexed citations
19.
McMahon, James, Michael R. Jordan, Kent R. Kelley, et al.. (2011). Pharmacy Adherence Measures to Assess Adherence to Antiretroviral Therapy: Review of the Literature and Implications for Treatment Monitoring. Clinical Infectious Diseases. 52(4). 493–506. 119 indexed citations
20.
Guzik, Przemysław, et al.. (2000). Comparison of Fentanyl and Droperidol Mixture (Neuroleptanalgesia II) with Morphine on Clinical Outcomes in Unstable Angina Patients. Cardiovascular Drugs and Therapy. 14(3). 259–269. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026